First Horizon Corporation’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Sell
156,209
-4,255
-3% -$498K 0.77% 39
2026
Q1
$19.3M Buy
160,464
+44,269
+38% +$5.11M 0.81% 38
2025
Q4
$12.2M Sell
116,195
-3,426
-3% -$322K 0.55% 60
2025
Q3
$10M Buy
+119,621
New +$9.85M 0.47% 65
2021
Q2
$10.1M Sell
129,582
-5,676
-4% -$422K 0.9% 40
2021
Q1
$9.95M Buy
135,258
+7,201
+6% +$531K 0.95% 29
2020
Q4
$9.99M Sell
128,057
-14,378
-10% -$1.1M 0.98% 27
2020
Q3
$11.3M Buy
+142,435
New +$11.2M 1.2% 21
2013
Q2
$4.5M Buy
+101,410
New +$4.53M 1.23% 10

Other funds holding MRK

First Horizon Corporation's MRK Position: Q2 2026 in Review

First Horizon Corporation reduced its Merck (MRK) stake by 2.7% in Q2 2026, selling an estimated $498K and leaving 156,209 shares worth $20.1M. The position accounts for 0.77% of the portfolio, ranked #39.

First Horizon Corporation first reported a position in MRK in Q2 2013 and has held it in 9 quarters since. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • First Horizon Corporation held 156,209 shares of Merck worth $20.1M as of Q2 2026.
  • First Horizon Corporation sold 4,255 Merck shares in Q2 2026, an estimated $498K.
  • Merck made up 0.77% of First Horizon Corporation's portfolio in Q2 2026, its #39 holding.
  • First Horizon Corporation first reported a position in Merck in Q2 2013 and has held it in 9 quarters since.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.